BANGKOK -- Siam Bioscience, a Thai drugmaker owned by the royal family, has started the country's first production of a COVID-19 vaccine, using AstraZeneca's technology.
The shots will be supplied for domestic use. Shipment volumes and other details have not been disclosed, but Public Health Minister Anutin Charnvirakul said on Tuesday that 6 million doses would be delivered this month, according to the Bangkok Post.
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
